Cargando…
Body Weight Control by a High-Carbohydrate/Low-Fat Diet Slows the Progression of Diabetic Kidney Damage in an Obese, Hypertensive, Type 2 Diabetic Rat Model
Obesity is one of several factors implicated in the genesis of diabetic nephropathy (DN). Obese, hypertensive, type 2 diabetic rats SHR/NDmcr-cp were given, for 12 weeks, either a normal, middle-carbohydrate/middle-fat diet (MC/MF group) or a high-carbohydrate/low-fat diet (HC/LF group). Daily calor...
Autores principales: | Ohtomo, Shuichi, Izuhara, Yuko, Nangaku, Masaomi, Dan, Takashi, Ito, Sadayoshi, van Ypersele de Strihou, Charles, Miyata, Toshio |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2911582/ https://www.ncbi.nlm.nih.gov/pubmed/20700413 http://dx.doi.org/10.1155/2010/136502 |
Ejemplares similares
-
Plasminogen Activator Inhibitor-1 Antagonist TM5484 Attenuates Demyelination and Axonal Degeneration in a Mice Model of Multiple Sclerosis
por: Pelisch, Nicolas, et al.
Publicado: (2015) -
A European Exchange Scheme for Junior Doctors in Internal Medicine 1977–91: Experiences of Participants and Organisers
por: Van Ypersele De Strihou, Charles, et al.
Publicado: (1995) -
Efficacy and safety of esaxerenone (CS-3150) in Japanese patients with type 2 diabetes and macroalbuminuria: a multicenter, single-arm, open-label phase III study
por: Ito, Sadayoshi, et al.
Publicado: (2021) -
Reduction in the magnitude of serum potassium elevation in combination therapy with esaxerenone (CS‐3150) and sodium–glucose cotransporter 2 inhibitor in patients with diabetic kidney disease: Subanalysis of two phase III studies
por: Shikata, Kenichi, et al.
Publicado: (2022) -
Modified Atkins Diet with slow reduction of carbohydrate
por: Gauthier, Amanda, et al.
Publicado: (2019)